Three fictional follow-up records, not three levels of success

Both visits ask about the preceding 30 days. This window belongs to the example, not a universal definition of current use. No row measures other nicotine products.

First visitNext visitWhat was reportedWhat remains unknown
Both productsCigarettes onlyThe next window still includes cigarettesWhy the electronic cigarette was no longer reported
Both productsLiquid electronic cigarette onlyNo cigarettes reported in that next windowWhether smoking stopped continuously or will remain stopped
Both productsNeither of the twoNeither product reported in that next windowOther nicotine or tobacco use; longer-term status

First ask what was counted

Check the product names as well as the dates. Here ‘electronic cigarette’ means a device heating liquid; heated-tobacco products are not folded into the same category. A survey that counts any recent use and another that requires current daily or some-day use may place the same account in different groups.

NCHS describes several US data systems with different tobacco-use definitions. A 2022 analysis of adult US PATH data from 2013–2017 also found that definitions and the treatment of low-frequency use affected some estimated transitions. That is a reason to read the definition, not to conclude that every finding changes or that one definition applies everywhere.

[2][3]

Two observations add information, but not a cause

Suppose a fictional questionnaire asks about the preceding 30 days at each of two visits. At the first visit, both products are reported. Different answers at the next visit describe different observed states, as the table shows. These are examples, not study results or recommended routes.

Even two reports leave intervals between observations. They do not date every change, prove continuous abstinence or explain whether a particular intervention caused it. ‘Neither of these two products’ also leaves other nicotine or tobacco products unmeasured.

[3]

Less smoking and stopped smoking answer different questions

A reduction in cigarette use can be a reported change without being cigarette cessation. A quit attempt, a report of no current smoking and a measured chemical in a biological sample also have different endpoints. Giving them all the label ‘progress’ would hide what was actually observed.

The CDC cautions that adding electronic cigarettes while continuing to smoke does not provide an effective way to safeguard health. A dual-use classification is therefore neither a health certificate nor an individual risk calculation.

[1]

A clearer opening for a support conversation

You could say: ‘I have used cigarettes and a liquid-based electronic cigarette during this period. I want help stopping smoking; what support covers both?’ A qualified local service can clarify its scope rather than treating the label as a diagnosis.

In the United States, the CDC points to 1-800-QUIT-NOW for smoking-cessation support. English-speaking readers elsewhere should use their local qualified service and confirm help for the products they actually use.

[1]

What to keep in mind

  • Read the products, observation period and frequency rule before interpreting the label.
  • Follow-up can describe a change; it does not by itself prove why it happened.
  • Reporting neither product is not the same as stopping every nicotine product.

Sources

The central claims on this page were checked against the sources below.

  1. US Centers for Disease Control and Prevention: Dual Use of Tobacco Products — reviewed 2025-02-24

    Sources checked: 2026-10-02

  2. US National Center for Health Statistics: Tobacco use — updated 2026-09-16

    Sources checked: 2026-10-02

  3. Brouwer AF and colleagues / PubMed, US National Library of Medicine: The Impact of Current Tobacco Product Use Definitions on Estimates of Transitions Between Cigarette and ENDS Use — Nicotine & Tobacco Research 24(11):1756–1762, 2022; author abstract

    Sources checked: 2026-10-02

General explanation of population-observation methods. No personal dependence diagnosis, product-switching advice, exposure calculation or treatment plan.